Loading insider details...
Beta
Latest Form 4 (Jul 21, 2026): Grant/Award of 136 ARTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 21, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 136 | n/a |
| Feb 2, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 292 | n/a |
| Jan 30, 2025 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 500,000 | n/a |
| Dec 23, 2024 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 1,750 | n/a |
| Jun 18, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 125,000 | n/a |
| Mar 2, 2024 | ARTELO BIOSCIENCES, INC. (ARTL) | Disposition to Issuer | 1,484 | n/a |
| Feb 2, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 438,000 | n/a |
| Aug 8, 2023 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 1,083 | n/a |
| Jul 3, 2023 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 667 | n/a |
| Jun 8, 2023 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 600,000 | n/a |